Article content

The hierarchy at Aphria Inc. had a busy week positioning the company for a significant expansion of its cannabis production in the wake of the federal government’s plan to legalize pot next year.

The Leamington-based producer of medical cannabis products announced Thursday it had secured $100 million to fund continued expansion and strategic investment.

We apologize, but this video has failed to load.

tap here to see other videos from our team. Try refreshing your browser, or Medical cannabis producer plans to grow again Back to video

That came on the heels of Wednesday’s joint announcement with Tetra Bio-Pharma Inc. to distribute dried medical cannabis in the Maritime provinces and Quebec.

Tetra and Aphria are also working towards developing a prescription drug that would be marketed in both the U.S. and Canada.

“It really goes back to our vision of Aphria of having one million square feet of greenhouse grow,” CEO Vic Neufeld said.

Photo by Dan Janisse / Windsor Star

Aphria negotiated a $75-million equity financing deal with Clarus Securities Inc. with the sale of just over 11.5 million common shares at $6.50 per share.